By Karen Roman Agendia, Inc. said it will present data to assess treatment decisions on patients with early-stage breast cancer at the San Antonio ...
News
- Agendia To Unveil Enhanced Breast Cancer Therapy at San Antonio - Yahoo
- Intensity Therapeutics, Inc. and The Swiss Group for Clinical Cancer Research SAKK ... - ABC4 Utah
("Intensity" or "the Company") (Nasdaq: INTS), a late-stage clinical biotechnology ... San Antonio Breast Cancer Symposium being held December 10-13, at ...
- BriaCell 2024 SABCS® Poster Highlights Ability of Bria-IMT™ Regimen to Increase Cancer ...
... San Antonio Breast Cancer Symposium ® at Henry B. Gonzalez Convention Center, San Antonio, TX. Today's poster shows influx of cancer fighting ...
- Monte Rosa Therapeutics Appoints Dr. Eric A. Hughes to Board of Directors - Quantisnow
Biotechnology: Biological Products (No Diagnostic Substances). Health Care. Monte Rosa Therapeutics Presents Preclinical Data at the 2024 San Antonio ...
- BriaCell 2024 SABCS® Poster Highlights Ability of Bria-IMT™ Regimen to Increase Cancer ...
(Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology ... San Antonio Breast Cancer Symposium ® at Henry B.